Reporting owner
Ghias Babar
Reporting owner CIK 0002076862 · Chief Financial Officer
These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.
Transaction timeline
Who reported an acquisition, and when the transaction occurred.
2 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.
View timeline as a table
| Transaction date | Company / security | Reporting owners | Acquisition type |
|---|---|---|---|
| Dec 17, 2025 | BIOCRYST PHARMACEUTICALS INCEmp. Stock Option (Right to Buy) | Ghias Babar | Stock award |
| Dec 17, 2025 | BIOCRYST PHARMACEUTICALS INCCommon Stock | Ghias Babar | Stock award |
Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.
Transactions in associated filings
| Filed / transacted | Company | Reporting owners | Type / security | Quantity | Price / reference value | Details |
|---|---|---|---|---|---|---|
| Trade: | BIOCRYST PHARMACEUTICALS INCBCRX · company listings | Ghias BabarChief Financial Officer | Stock awardEmp. Stock Option (Right to Buy)Derivative security · Code A | 355,050 | 0Value: 0Currency not specified | View ↗ |
| Trade: | BIOCRYST PHARMACEUTICALS INCBCRX · company listings | Ghias BabarChief Financial Officer | Stock awardCommon StockNon-derivative security · Code A | 121,700 | 0Value: 0Currency not specified | View ↗ |
2 transactions on this page. Filing date, newest first.